Rovazolac is a liver x receptor (LXR) modulator extracted from patent WO2013130892A1.
Rovazolac is an anti-inflammatory drug candidate[1].
[1]. Mohan R. Preparation of substituted pyrazoles as liver X receptor (LXR) modulators useful for the treatment of dermal diseases, disorders and conditions. WO2013130892A1
















